← All trials
NCT03010735
Phase 2/Phase 3Interventional
Trials that are a combination of phases 2 and 3.
View on ClinicalTrials.gov ↗Timeline
- Start date
- Jun 1, 2015
- Primary completion
- Feb 1, 2017
- Completion date
- Dec 1, 2017
- First posted
- —
- Last posted
- —
- Enrollment
- 150
- Arms / groups
- 2 / —
- Source
- AACT · pre-existing
Sponsors
- China Agricultural UniversityLead sponsor
- China Agricultural UniversityOverall official - principal investigator
- China Agricultural UniversityReponsible party - principal investigator
- General Hospital of Chinese Armed Police ForcesCollaborator
- Capital Medical UniversityCollaborator
- Beijing Biostats Technology Co. Ltd.Collaborator
- Beijing Heyiyuan Biotech Co. Ltd.Collaborator
- Peking UniversityCollaborator
Drugs studied
Indications studied
CDEK-curated fields only — the ClinicalTrials.gov results mirror (baseline measures, adverse events, participant flow) is a separate, currently-dormant pipeline; see MIGRATION_PLAN.md.